Mechanisms of Action of Combination Motivational Interviewing-Cognitive Behavior Therapy for Reversing Medication Non-Adherence in Patients With Multiple Sclerosis.
Document Type
Article
Publication Date
7-2025
Identifier
DOI: 10.1002/jclp.23796
Abstract
OBJECTIVE: Despite disease modifying therapies' (DMT) demonstrated efficacy for treating relapsing MS, around 40% of patients discontinue use. This study aimed to understand the mechanism of action of Motivational Interviewing plus cognitive behavioral therapy (MI-CBT) in a previously conducted randomized controlled trial in which the MI-CBT intervention successfully promoted DMT re-initiation of participants compared to a treatment as usual (TAU) condition.
METHODS: This secondary analysis (N = 91) explored changes in motivation (a single item motivation "ruler" [Mot∆], and the Brief Motivation Scale [BMS∆]), autonomous motivation (AR∆), personal control (PC∆), treatment control (TC∆), and confidence to reinitiate (Con∆) as potential mediators of the treatment effect, using logistic regression.
RESULTS: Logistic regression analysis including all potential mediators as predictors of initiation indicated the BMS∆ was the only statistically significant predictor (OR = 1.61, p = 0.010). When BMS∆ was removed Mot∆ (OR = 1.22, p = 0.002) and PC∆ (OR = 1.67, p = 0.002) were statistically significant predictors of initiation.
CONCLUSION: The MI-CBT intervention appeared to work primarily by increasing motivation to initiate DMT.
Journal Title
Journal of clinical psychology
Volume
81
Issue
7
First Page
609
Last Page
618
MeSH Keywords
Humans; Motivational Interviewing; Cognitive Behavioral Therapy; Female; Male; Adult; Middle Aged; Motivation; Medication Adherence; Combined Modality Therapy; Multiple Sclerosis
PubMed ID
40176571
Keywords
MI‐CBT; adherence; behavioral medicine; chronic illness; health behavior; health promotion; mediator
Recommended Citation
Schoor R, Bruce JM, Staggs VS, et al. Mechanisms of Action of Combination Motivational Interviewing-Cognitive Behavior Therapy for Reversing Medication Non-Adherence in Patients With Multiple Sclerosis. J Clin Psychol. 2025;81(7):609-618. doi:10.1002/jclp.23796


Comments
Grants and funding